Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease. (Record no. 1407772)

MARC details
000 -LEADER
fixed length control field 01462 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250511182836.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199211s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0190-9622
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/0190-9622(92)70213-y
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Stiller, M J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19921112
245 00 - TITLE STATEMENT
Title Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of the American Academy of Dermatology
Date of publication, distribution, etc. Sep 1992
300 ## - PHYSICAL DESCRIPTION
Extent 434-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Blood Pressure
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclosporine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hyperlipidemias
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psoriasis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Factors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pak, G H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kenny, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jondreau, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Davis, I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wachsman, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shupack, J L
773 0# - HOST ITEM ENTRY
Title Journal of the American Academy of Dermatology
Related parts vol. 27
-- no. 3
-- p. 434-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/0190-9622(92)70213-y">https://doi.org/10.1016/0190-9622(92)70213-y</a>
Public note Available from publisher's website

No items available.